Vor Biopharma Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $-36.3M | $-40.5M | $4.2M | $1.3M |
| FY2021 | $-69.1M | $-73.0M | $3.9M | $4.3M |
| FY2022 | $-85.1M | $-93.6M | $8.5M | $10.7M |
| FY2023 | $-100.3M | $-101.4M | $1.1M | $13.4M |
| FY2024 | $-99.7M | $-99.9M | $229.0K | $9.8M |
| FY2025 | $-142.7M | $-143.7M | $941.0K | $18.9M |